Report Code: A12328 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Hemorrhagic Stroke Drugs Market
Request Now !Hemorrhagic stroke, commonly known as cerebral hemorrhage, is a condition caused by the rupturing of cerebral blood vessels. Hemorrhagic stroke is mainly of two types - intracerebral hemorrhage and subarachnoid hemorrhage. Intracerebral hemorrhage happens when a deteriorated blood vessel inside the brain ruptures and leaks blood into neighboring brain tissues.
Aneurysms and arteriovenous malformations are the damaged blood vessels that usually cause hemorrhagic stroke. Overuse of antihypertensive drugs is often held responsible for hemorrhagic stroke. In the brain, bleeding occurs due to brain tumor, accidents, stroke, or high blood pressure, or other health conditions. Of all the stroke cases, 13% strokes are hemorrhagic strokes. Still, it is accountable for about 40% of all stroke casualties and signifies the extremely severe subtypes of stroke.
COVID-19 Impact Analysis
COVID-19 has left tremendous pressure on healthcare services. With the anticipated pathophysiological mechanism of neurologic injury by COVID-19, it was expected that the frequency of stroke and hospital admissions were expected to increase. But neurologists in recent months from different parts of the world have notified a fair drop in the volume of acute 0stroke patients visiting emergency care.
A study done by the National Institute of Neurosciences and Hospital (NINS&H) revealed more than 50% decrease in acute stroke admission throughout the COVID-19 pandemic. Whether the reduction is related to the overall restriction on public movement by the government or is it the concern of getting infected by COVID-19 from hospitalization remains unidentified.
Top Impacting Factors
Market Trends
New Product Launches to Flourish the Market
In November, 2020, AstraZeneca’s Brilinta (ticagrelor) was approved in the U.S. to reduce the risk of stroke, a leading cause of disability and death worldwide.
In February 2020, Abbott Laboratories got the approval for Amplatzer Amulet left atrial appendage to occlude by the U.S. FDA for the people suffering from stroke. This approach assisted the company in expanding its stroke management product portfolio.
Surge in Usage in Hemorrhagic Stroke Treatment
The hemorrhagic stroke market has witnessed several novel therapies that are designed specifically to enhance stroke outcomes. In addition, rise in adoption of hemorrhagic stroke treatment can be credited to the current high unmet medical needs and entry of highly priced therapies in the market. Key players are aiming at advancement of new drugs and stem cell therapies with improved efficacy.
Key Benefits of the Report
Questions Answered in the Hemorrhagic Stroke Drugs Market Report
Hemorrhagic Stroke Drugs Market Report Highlights
Aspects | Details |
---|---|
By Type |
|
By End User |
|
By Region |
|
Key Market Players | AstraZenica, Amneal Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., Zydus Cadila, Bristol-Myers Squibb Company, Daiichi Sankyo Company, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim International GmbH, Novartis AG, Johnson and Johnson Services, Inc. |
Start reading.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers